MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: news
news

Adding HE4 to the IOTA ADNEX Model for Differentiating Adnexal Masses: A Danish Prospective Multicenter Study

MedXY Editorial TeamMay 18, 2026
HE4ovarian cancer riskGynecologic OncologyADNEX model

Overview

A Danish prospective multicenter study has examined whether adding human epididymis protein 4, known as HE4, to the IOTA ADNEX model improves the ability to distinguish benign from malignant adnexal masses. Adnexal masses are growths in the region of the ovaries, fallopian tubes, or nearby pelvic structures. Correctly identifying which masses are likely to be cancerous is important because it helps guide referral, surgery, follow-up, and counseling.

The study found that HE4 added only limited value overall. In a tertiary referral center, performance improved slightly in some risk thresholds, but in non-tertiary centers the addition of HE4 did not meaningfully improve the model. Overall, the results do not support routinely adding HE4 to the ADNEX model.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story